HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.

Abstract
A piperazine-containing benzothiazinones lead compound PBTZ169, served as DprE1 inhibitor, displays nanomolar bactericidal activity against Mycobacteria tuberculosis. Here, we systematically evaluate anti-tuberculosis activity of one of PBTZ169 analogues, TZY-5-84, in vitro and in vivo. The MIC value of TZY-5-84 against M. tuberculosis H37Rv ranged from 0.014 to 0.015 mg/L, lower than those of INH, RFP and BDQ. Five susceptible and thirteen drug-resistant clinical isolates were also susceptive to TZY-5-84. It had anti-tuberculosis activity against intracellular bacilli in infected macrophage model. It exhibited its activity in time-dependent manner and against intracellular bacilli in infected macrophage cells. However, the MIC of TZY-5-84 against three laboratory PBTZ169-induced resistant isolates increased four-fold increment compared to that of H37Rv. No antagonism was observed in any combination between TZY-5-84 and seven commonly used anti-tuberculosis drugs in an in vitro checkerboard assay. In murine infection model, TZY-5-84 at lower dosage (12.5 mg/kg) was found to be comparatively efficacious as PBTZ169 at 25 mg/kg. Our research suggests TZY-5-84 can be a promising preclinical candidate for further study on TB treatment.
AuthorsShaochen Guo, Lei Fu, Bin Wang, Xi Chen, Jiaojie Zhao, Mingliang Liu, Yu Lu
JournalBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother) Vol. 131 Pg. 110777 (Nov 2020) ISSN: 1950-6007 [Electronic] France
PMID33152936 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Chemical References
  • Antitubercular Agents
  • Piperazines
  • Thiazines
  • Piperazine
  • macozinone
Topics
  • Animals
  • Antitubercular Agents (administration & dosage, pharmacology)
  • Dose-Response Relationship, Drug
  • Female
  • Macrophages (drug effects, microbiology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C3H
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis (drug effects, isolation & purification)
  • Piperazine (chemistry)
  • Piperazines (administration & dosage, chemistry, pharmacology)
  • Thiazines (administration & dosage, chemistry, pharmacology)
  • Time Factors
  • Tuberculosis (drug therapy, microbiology)
  • Tuberculosis, Multidrug-Resistant (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: